Literature DB >> 18681883

Exacerbation of pemphigus after influenza vaccination.

C De Simone1, G Caldarola, M D'agostino, A Zampetti, P Amerio, C Feliciani.   

Abstract

Pemphigus is a rare autoimmune disease characterized by flaccid blisters and erosions on skin and mucous epithelia. A critical event in its pathogenesis is production of antidesmoglein antibodies, which mediate the loss of intercellular adhesion in epithelia, leading to blister formation. Multiple environmental factors (ultraviolet radiation, trauma, drugs, infective agents) have been suggested as possible triggers of pemphigus. Occasionally, the disease has been reported to follow viral and bacterial vaccination. We describe a patient who experienced exacerbation of pemphigus shortly after administration of the influenza vaccination on two separate occasions. We review the literature, suggest possible explanations for a causal relationship, and discuss the administration of vaccination to these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18681883     DOI: 10.1111/j.1365-2230.2008.02835.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  Pemphigus vulgaris: A dermatological sequel of severe H1N1 infection.

Authors:  Preema Sinha; Manas Chatterjee; Biju Vasudevan
Journal:  Indian Dermatol Online J       Date:  2014-04

Review 2.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

Review 3.  Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.

Authors:  Ajeet Singh; Sujana J Bharadwaj; Anju G Chirayath; Satyaki Ganguly
Journal:  J Cosmet Dermatol       Date:  2022-04-09       Impact factor: 2.189

4.  New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 cases.

Authors:  Haiwen Gui; Peter A Young; Jodi Y So; Marlyanne Pol-Rodriguez; Kerri E Rieger; Matthew A Lewis; Marten C G Winge; Gordon H Bae
Journal:  JAAD Case Rep       Date:  2022-07-09

5.  Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?

Authors:  Nika Kianfar; Shayan Dasdar; Ali Salehi Farid; Kamran Balighi; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Front Med (Lausanne)       Date:  2022-07-19

6.  New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination.

Authors:  Mina Almasi-Nasrabadi; Radha S Ayyalaraju; Ashish Sharma; Somaia Elsheikh; Shanti Ayob
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-14       Impact factor: 9.228

7.  Pemphigus vulgaris and COVID-19 vaccination: Management and treatment.

Authors:  Fabrizio Martora; Teresa Battista; Paola Nappa; Gabriella Fabbrocini; Matteo Megna
Journal:  J Cosmet Dermatol       Date:  2022-09-09       Impact factor: 2.189

8.  Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective.

Authors:  Marta Mazur; Irena Duś-Ilnicka; Maciej Jedliński; Artnora Ndokaj; Joanna Janiszewska-Olszowska; Roman Ardan; Malgorzata Radwan-Oczko; Fabrizio Guerra; Valeria Luzzi; Iole Vozza; Roberto Marasca; Livia Ottolenghi; Antonella Polimeni
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.